Who Owns Eledon Pharmaceuticals Stock?
NASDAQ: ELDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 58.64%
- Held by insiders
- 0.33%
- Institutional holders
- 202
- Institutions 58.6%
- Insiders 0.3%
- Public and other 41.0%
Who owns Eledon Pharmaceuticals stock?
Institutional investors own about 58.6% of Eledon Pharmaceuticals's shares, spread across 202 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.33% of ELDN.
The largest institutional holders are BVF Inc. (7.74%), Blackrock Inc. (6.31%) and Defilade Capital Management, L.P. (4.34%). Together, the top 10 institutions control 36.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ELDN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ELDN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| BVF Inc. | 6.29M | 7.74% | 0.0% |
| Blackrock Inc. | 5.12M | 6.31% | +16.9% |
| Defilade Capital Management, L.P. | 3.53M | 4.34% | -1.1% |
| Vanguard Capital Management LLC | 3.42M | 4.21% | +3.8% |
| Goldman Sachs Group Inc | 2.51M | 3.09% | +578.3% |
| Ensign Peak Advisors, Inc | 2.10M | 2.59% | -14.8% |
| Geode Capital Management, LLC | 1.96M | 2.41% | +9.2% |
| Catalio Capital Management, LP | 1.70M | 2.09% | +3.4% |
| State Street Corporation | 1.62M | 2.00% | +40.5% |
| Zimmer Partners, Lp | 1.60M | 1.96% | -14.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ELDN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.48M | 3.06% |
| iShares Trust-iShares Russell 2000 ETF | 2.01M | 2.47% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 854.63K | 1.05% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 839.21K | 1.03% |
| iShares Trust-iShares Russell 2000 Growth ETF | 728.95K | 0.90% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 383.98K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 355.04K | 0.44% |
| Goldman Sachs Trust-Goldman Sachs Small Cap Equity Insights Fund | 311.99K | 0.38% |
| Goldman Sachs Trust-Goldman Sachs Small Cap Value Insights Fund | 286.01K | 0.35% |
| iShares Trust-iShares Micro-Cap ETF | 261.65K | 0.32% |
Frequently asked questions
Who is the largest shareholder of Eledon Pharmaceuticals?
BVF Inc. is the largest institutional shareholder of ELDN, owning 7.74% of shares outstanding (6.29M shares) as of its latest 13F filing.
What percentage of Eledon Pharmaceuticals is owned by institutions?
Institutions own about 58.6% of ELDN shares and 58.8% of the public float.
How much of Eledon Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.33% of ELDN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.